Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • DNA signature in Ice Storm babies: Prenatal maternal stress exposure to natural disasters predicts epigenetic profile of offspring

  • Chefs at schools can increase school meal participation, vegetable intake among students

  • Improving babies' language skills before they're even old enough to speak

  • After-school exercise program enhances cognition in 7-, 8- and 9-year-olds

  • How career dreams are born

  • Who are the men, boys suffering from anorexia?

  • Feeling fatigued while driving? Don't reach for your music

  • New clues revealed to understand brain stimulation

  • What makes a song sing? Backup singers

  • Transplant drug could boost power of brain tumor treatments, study finds

  •